News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Japan Approves AstraZeneca PLC’s (JOBS) Symbicort
October 16, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AP -- Drugmaker AstraZeneca PLC said Friday that its Symbicort inhaler has been approved in Japan for use as a treatment for asthma in adults.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
AstraZeneca
MORE ON THIS TOPIC
Cancer
Replimune gets early August decision date for twice-rejected melanoma drug
June 26, 2026
·
3 min read
·
Tristan Manalac
FDA
BIO 2026: FDA’s IND initiative is a step toward normalization after slipshod year
June 25, 2026
·
3 min read
·
Jef Akst
Approvals
Ionis secures market expansion for Tryngolza as FDA clears severe hypertriglyceridemia use
June 25, 2026
·
2 min read
·
Tristan Manalac
Approvals
Gilead’s TROP-2 Trodelvy, Keytruda combo win first-line FDA nods for breast cancer
June 25, 2026
·
1 min read
·
Tristan Manalac
